Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin™ For The Treatment Of Chronic Bacterial Infections In Cystic Fibrosis Patients
Links shared publicly online about this topic.
- 588total visits
Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin™ For The Treatment Of Chronic Bacterial Infections In Cystic Fibrosis Patients
Mpex Pharmaceuticals, Inc. during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin™ (MP-376) for the treatmen
View full resource at medicalnewstoday.com
Tags: Infection, Bacterial Infection, Cystic Fibrosis, Healthcare, Pharma, Phase 3 Clinical Trial, Clinical Trial
Most Recently Shared on January 11, 2011 at 8:05 pm By:
Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin™ For The Treatment Of Chronic Bacterial Infections I... http://mnt.to/3PR8
Also Shared By:
Phase 3 study of Aeroquin for the treatment of cystic fibrosis (CF) - MPR
empr.com — “Mpex Pharmaceuticals announced the initiation of a Phase 3 trial program with Aeroquin (levofloxacin aerosol), also known as MP-36, for the maintenance treatment of bacterial infections associated with cystic fibrosis (CF).” View full resource at empr.com
Most Recently Shared on January 12, 2011 at 4:13 pm By:
MPR News: Phase 3 study of Aeroquin for the treatment of cystic fibrosis (CF): Mpex Pharmaceuticals announced th... http://bit.ly/fPCHhX
Advertisement
MNT Cystic Fibrosis
@mnt_cysticfibro
Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin™ For The Treatment Of Chronic Bacterial Infections I... http://mnt.to/3PR8
1 year ago...